Indian Develops Innovative Anti-Ageing Formulation

New Delhi: Pharma consultant and US-based Alkomex GBN Pharma Group’s scientific advisor Sanjay Agrawal has sought a patent for an anti-ageing drug formulation.

According to the Ahmedabad-based researcher, he has developed a drug formulation to tackle ageing at the cellular level and is awaiting a patent for the same.

He has applied for a patent at the Indian Patent Office. Agrawal, who holds over 42 patents for unique drug formulations, claims that besides addressing ageing at a cellular level, the drug formulation has the potential to significantly improve skin health, boost energy levels and enhance overall vitality. “Anti-ageing medicine, a revolutionary scientific discipline, is redefining how we approach the ageing process,” Agrawal said.

By focusing on advanced technologies, early detection, prevention, and reversal of age-related dysfunctions, anti-ageing medicine aims to enhance physical, functional, and aesthetic well-being, he added. “Our new formulation will further boost the prospects of the domain, as with targeted benefits and innovative ingredients, the formulation is poised to make a lasting impact in the fight against age-related decline,” he said.